Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog > N-Nitroso Tadalafil
 N-Nitroso Tadalafil
  •  N-Nitroso Tadalafil
  •  N-Nitroso Tadalafil
  •  N-Nitroso Tadalafil
  •  N-Nitroso Tadalafil
  •  N-Nitroso Tadalafil

N-Nitroso Tadalafil NEW

Price Get Latest Price
Package 10mg 50mg 100mg
Min. Order: 10mg
Supply Ability: 1000
Update Time: 2025-07-31

Product Details

Product Name: N-Nitroso Tadalafil Min. Order: 10mg
Purity: 99%+ HPLC Supply Ability: 1000
Release date: 2025/07/31

 N-Nitroso Tadalafil

Article illustration


Product Information

  • Product Code: T007086

  • English Name: N-Nitroso Tadalafil

  • English Alias: (6R,12aR)-6-(benzo[d][1,3]dioxol-5-yl)-2-methyl-7-nitroso-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione

  • CAS No.: Not provided

  • Molecular Formula: C₂₂H₁₈N₄O₅

  • Molecular Weight: 418.40

Advantages

  • As a nitroso derivative impurity of Tadalafil, it is used for pharmaceutical quality control and safety assessment to ensure that the content of such impurities in Tadalafil API and formulations meets the requirements of pharmacopoeias and regulations.

  • The nitroso group (-NO) in the structure may serve as a characteristic impurity for impurity profile analysis, helping pharmaceutical companies optimize production processes and reduce potential genotoxic risks.

Applications

  • Drug R&D and Quality Control: As a reference standard for qualitative and quantitative analysis of impurities in Tadalafil-related drugs, such as the development and validation of HPLC, LC-MS and other detection methods.

  • Safety Evaluation: Nitroso compounds may have potential toxicity. The study of this impurity can assist in evaluating the safety of Tadalafil products and provide data support for drug registration and regulatory submission.

Background Description

Tadalafil is a PDE5 inhibitor used in the treatment of male erectile dysfunction. During drug production, various impurities may be generated due to synthesis processes, storage conditions, etc. The formation of nitroso impurities (such as N-Nitroso Tadalafil) is related to raw material residues, reaction by-products, or oxidation processes. Nitroso compounds are considered to have potential carcinogenicity in some studies, so pharmacopoeias (such as USP, EP) have become increasingly strict in controlling such impurities, driving the demand and research of related impurity reference standards.

Research Status

  • Analytical Method Research: The current detection of nitroso impurities mostly uses high-sensitivity chromatography-mass spectrometry technology, with the focus on optimizing the limit of detection and limit of quantification to meet the regulatory requirements for trace impurities.

  • Toxicity Risk Assessment: Some studies focus on the potential genotoxicity of such impurities, and establish safe exposure limits through toxicological experiments to provide a basis for pharmaceutical impurity control standards.

  • Process Control: The pharmaceutical industry is reducing the formation of nitroso impurities by optimizing synthetic routes and improving purification processes. Related impurity reference standards play a key role in process validation.



WhatsAPP: +86 17320513646
E-mail: anna@molcoo.com


NOTE!

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17320513646
E-mail: anna@molcoo.com


NEW IN STOCK!

The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery! 


Company Profile Introduction

-

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/10mg
VIP2Y
ShenZhen H&D Pharmaceutical Technology Co., LTD
2025-03-19
$0.00/10mg
VIP1Y
Guangzhou Weiaokang Pharmaceutical Technology Co., Ltd
2025-08-01
$8.00/1kg
VIP2Y
Henan Fengda Chemical Co., Ltd
2024-04-24
INQUIRY